Clinical Trial Update: The Spectralis-Cirrus Study

View source ↗

Summary

The Spectralis-Cirrus Study evaluating imaging in exudative age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Conditions: Exudative Age Related Macular Degeneration | Status: COMPLETED